NO176277C - Analogifremgangsmåte for fremstilling av terapeutisk aktive 3,4-dihydro-2-alkyl-3-okso-N-aryl-2H-[1Åbenzotieno[3,2-eÅ-1,2-tiazin-4-karboksamid-1,1-dioksyder - Google Patents

Analogifremgangsmåte for fremstilling av terapeutisk aktive 3,4-dihydro-2-alkyl-3-okso-N-aryl-2H-[1Åbenzotieno[3,2-eÅ-1,2-tiazin-4-karboksamid-1,1-dioksyder

Info

Publication number
NO176277C
NO176277C NO890531A NO890531A NO176277C NO 176277 C NO176277 C NO 176277C NO 890531 A NO890531 A NO 890531A NO 890531 A NO890531 A NO 890531A NO 176277 C NO176277 C NO 176277C
Authority
NO
Norway
Prior art keywords
alkyl
dihydro
oxo
aryl
therapeutically active
Prior art date
Application number
NO890531A
Other languages
English (en)
Other versions
NO890531L (no
NO176277B (no
NO890531D0 (no
Inventor
Anthony Marfat
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO890531L publication Critical patent/NO890531L/no
Publication of NO890531D0 publication Critical patent/NO890531D0/no
Priority to NO922636A priority Critical patent/NO922636D0/no
Publication of NO176277B publication Critical patent/NO176277B/no
Publication of NO176277C publication Critical patent/NO176277C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
NO890531A 1987-06-10 1989-02-08 Analogifremgangsmåte for fremstilling av terapeutisk aktive 3,4-dihydro-2-alkyl-3-okso-N-aryl-2H-[1Åbenzotieno[3,2-eÅ-1,2-tiazin-4-karboksamid-1,1-dioksyder NO176277C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO922636A NO922636D0 (no) 1987-06-10 1992-07-03 Fremgangsmaate for fremstilling av 2,4-dihydro-2-alkyl-3-okso-2h-(1)benzotieno-(3,2-e)-1,2-tiazin-1,1-dioksyder

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/001357 WO1988009793A1 (en) 1987-06-10 1987-06-10 3,4-DIHYDRO-2-ALKYL-3-OXO-N-ARYL-2H-[1]BENZOTHIENO[3,2-e]-1,2-THIAZINE-4-CARBOXAMIDE-1,1-DIOXIDES
EP88304975A EP0294994B1 (en) 1987-06-10 1988-06-01 3-4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-el]-1,2-thiazine-4-carboxamide-1,1-dioxides

Publications (4)

Publication Number Publication Date
NO890531L NO890531L (no) 1989-02-08
NO890531D0 NO890531D0 (no) 1989-02-08
NO176277B NO176277B (no) 1994-11-28
NO176277C true NO176277C (no) 1995-03-08

Family

ID=55448100

Family Applications (2)

Application Number Title Priority Date Filing Date
NO890531A NO176277C (no) 1987-06-10 1989-02-08 Analogifremgangsmåte for fremstilling av terapeutisk aktive 3,4-dihydro-2-alkyl-3-okso-N-aryl-2H-[1Åbenzotieno[3,2-eÅ-1,2-tiazin-4-karboksamid-1,1-dioksyder
NO922636A NO922636D0 (no) 1987-06-10 1992-07-03 Fremgangsmaate for fremstilling av 2,4-dihydro-2-alkyl-3-okso-2h-(1)benzotieno-(3,2-e)-1,2-tiazin-1,1-dioksyder

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO922636A NO922636D0 (no) 1987-06-10 1992-07-03 Fremgangsmaate for fremstilling av 2,4-dihydro-2-alkyl-3-okso-2h-(1)benzotieno-(3,2-e)-1,2-tiazin-1,1-dioksyder

Country Status (28)

Country Link
US (1) US4914101A (no)
EP (1) EP0294994B1 (no)
JP (1) JPH078874B2 (no)
KR (1) KR900006758B1 (no)
CN (1) CN1019576B (no)
AT (1) ATE105561T1 (no)
AU (1) AU593743B2 (no)
CA (1) CA1300625C (no)
CZ (1) CZ281857B6 (no)
DD (1) DD281602A5 (no)
DE (1) DE3889497T2 (no)
DK (1) DK313388A (no)
EG (1) EG18525A (no)
ES (1) ES2051846T3 (no)
FI (1) FI89802C (no)
HU (1) HU203762B (no)
IE (1) IE63214B1 (no)
IL (1) IL86602A (no)
MX (1) MX174093B (no)
MY (1) MY103572A (no)
NO (2) NO176277C (no)
NZ (1) NZ224956A (no)
PH (1) PH25187A (no)
PL (1) PL158994B1 (no)
PT (1) PT87678B (no)
WO (1) WO1988009793A1 (no)
YU (1) YU46767B (no)
ZA (1) ZA884115B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0455830B1 (en) * 1989-11-30 1996-06-26 Nippon Hypox Laboratories Incorporated Medicine containing thiazine dioxide derivative
US6340659B1 (en) 1995-12-13 2002-01-22 The Lubrizol Corporation Metal salts of lactones as lubricant additives
JP4250344B2 (ja) 2001-01-29 2009-04-08 インターナショナル・ビジネス・マシーンズ・コーポレーション ワークフローシステム、ワークフローサーバ、および記憶媒体
US8741299B2 (en) 2011-06-20 2014-06-03 The Feinstein Institute For Medical Research Method for treating pathologies associated with hypoxia using MIF inhibitors
US9666805B2 (en) * 2014-11-25 2017-05-30 Northwestern University Bithiophene sulfonamide-based molecular and polymeric semiconductors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
CA1066711A (en) * 1974-08-26 1979-11-20 Hoffmann-La Roche Limited Thiophene derivatives
LU78009A1 (de) * 1977-08-22 1979-05-23 Hoffmann La Roche Verfahren zur herstellung von thiazinderivaten
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
DE2838377A1 (de) * 1978-09-02 1980-03-20 Thomae Gmbh Dr K Neue 4-hydroxy-2h eckige klammer auf 1 eckige klammer zu benzothieno eckige klammer auf 2,3-e eckige klammer zu -1,2- thiazin-3-carboxamid-1,1-dioxide sowie deren salze, deren verwendung und verfahren zu ihrer herstellung
AU5811280A (en) * 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives
ZA803401B (en) * 1979-06-13 1981-05-27 Hoffmann La Roche Thiazine derivatives

Also Published As

Publication number Publication date
KR900006758B1 (ko) 1990-09-20
PL158994B1 (pl) 1992-10-30
EP0294994B1 (en) 1994-05-11
CZ392588A3 (en) 1996-11-13
JPS6413093A (en) 1989-01-17
ES2051846T3 (es) 1994-07-01
IE881733L (en) 1988-12-10
NO890531L (no) 1989-02-08
AU1753588A (en) 1988-12-15
JPH078874B2 (ja) 1995-02-01
IL86602A (en) 1992-06-21
CZ281857B6 (cs) 1997-03-12
KR890000500A (ko) 1989-03-15
HU203762B (en) 1991-09-30
DK313388D0 (da) 1988-06-09
PT87678B (pt) 1992-10-30
PT87678A (pt) 1988-07-01
PL272928A1 (en) 1989-07-10
NO922636L (no) 1989-02-08
MX174093B (es) 1994-04-21
IE63214B1 (en) 1995-04-05
NZ224956A (en) 1990-07-26
EG18525A (en) 1994-04-30
AU593743B2 (en) 1990-02-15
FI890620A (fi) 1989-02-09
PH25187A (en) 1991-03-27
US4914101A (en) 1990-04-03
CN88103539A (zh) 1988-12-28
WO1988009793A1 (en) 1988-12-15
YU111988A (en) 1989-12-31
FI89802C (fi) 1993-11-25
DE3889497T2 (de) 1994-08-25
DD281602A5 (de) 1990-08-15
MX11827A (es) 1993-04-01
CN1019576B (zh) 1992-12-23
CA1300625C (en) 1992-05-12
NO922636D0 (no) 1992-07-03
EP0294994A1 (en) 1988-12-14
NO176277B (no) 1994-11-28
HUT54376A (en) 1991-02-28
YU46767B (sh) 1994-05-10
MY103572A (en) 1993-08-28
ATE105561T1 (de) 1994-05-15
NO890531D0 (no) 1989-02-08
DK313388A (da) 1988-12-11
FI890620A0 (fi) 1989-02-09
ZA884115B (en) 1990-02-28
IL86602A0 (en) 1988-11-30
FI89802B (fi) 1993-08-13
DE3889497D1 (de) 1994-06-16

Similar Documents

Publication Publication Date Title
AU7579094A (en) Methods for the treatment of peri-menopausal syndrome
HUT54142A (en) Process for producing 1,4-dihydropyridines and pharmaceutical compositions comprising such compounds
HU902020D0 (en) Process for producing tricyclic oxindole derivatives of antiphlogistic effect
NO176277C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3,4-dihydro-2-alkyl-3-okso-N-aryl-2H-[1Åbenzotieno[3,2-eÅ-1,2-tiazin-4-karboksamid-1,1-dioksyder
SE7609909L (sv) Nya penicilliner och forfarande for framstellning derav
AU538882B2 (en) 2,3-dihydro-imidazo(1,2-g)pyridazine derivatives
ES8605269A1 (es) Procedimiento para la fabricacion de derivados de tiadiazol activos sobre el sistema nervioso central
HUT63836A (en) Process for producing acridine derivatives